76Bio
San Francisco, United States · Founded 2020
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- 76bio.com
About
76Bio is a biotechnology company founded in 2020 that develops transformational therapies for patients with life-threatening diseases by pioneering a next generation of targeted protein degraders, including approaches that harness mRNA technology. The company was co-founded by biotech entrepreneur Arie Belldegrun, known for founding Kite Pharma, and closed a $55 million Series A financing round in January 2022.
Summary
76Bio is a Biotech company based in San Francisco, United States, founded in 2020.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...